A potential new treatment target for tumors — including a significant percentage of malignant brain tumors — driven by mutations in an important metabolic enzyme has been identified by a group of researchers.
A potential new treatment target for tumors — including a significant percentage of malignant brain tumors — driven by mutations in an important metabolic enzyme has been identified by a group of researchers.